Coronary atherosclerosis and interventions: Pathological sequences and restenosis

Keyphrases

• Coronary Intervention 100%
• Restenosis 100%
• Coronary Atherosclerosis 100%
• Percutaneous Transluminal Coronary Angioplasty 83%
• Acute Coronary Syndrome 50%
• Ischemic Heart Disease 33%
• Adventitial 33%
• Plaque Rupture 33%
• Plaque Disruption 33%
• Causal Factors 16%
• Developed Countries 16%
• Japan 16%
• United States 16%
• Japanese Patients 16%
• Macrophages 16%
• Patient Demographics 16%
• Over 40 16%
• Pathogenic Mechanism 16%
• Collagen Fibers 16%
• Old Japanese 16%
• Plaque 16%
• Coronary Artery Disease 16%
• Cardiovascular Center 16%
• Western Europe 16%
• Vascular Remodeling 16%
• Fibrous Plaque 16%
• Internal Elastic Lamina 16%
• Acquired Knowledge 16%
• Sudden Onset 16%
• Plaque Size 16%
• Adventitia 16%
• Foreign Body 16%
• Industrialized World 16%
• Prevalent Diseases 16%
• Cardiac Morbidity 16%
• Intravascular Ultrasound 16%
• Angioscopy 16%
• Molecular Biology Techniques 16%
• Coronary Risk Factors 16%
• Cardiac Mortality 16%
• Intimal Hyperplasia 16%
• In-stent Restenosis 16%
• Scar 16%
• Stent Replacement 16%
• Disruption Risk 16%
• Fatty Streak 16%
• Autopsy Study 16%
• Plaque Composition 16%
• Stent Design 16%
• Extracellular Lipids 16%
• Coronary Atherosclerotic Plaque 16%
• Coronary Stent 16%
• Tissue Factor Pathway inhibitor-2 (TFPI-2) 16%
• Granulomatous Reaction 16%

Medicine and Dentistry

• Restenosis 100%
• Transluminal Coronary Angioplasty 83%
• Atherosclerosis 50%
• Ischemic Heart Disease 50%
• Acute Coronary Syndrome 50%
• Disease 33%
• Stenting 33%
• Cardiovascular System 16%
• Morphology 16%
• Macrophage 16%
• Patient Population 16%
• Collagen Fiber 16%
• Granulomatous Inflammation 16%
• Adventitia 16%
• Vascular Remodeling 16%
• Foreign Body 16%
• Scar Formation 16%
• In-Stent Restenosis 16%
• Fatty Streak 16%
• Coronary Risk 16%
• Angioscopy 16%
• Intimal Hyperplasia 16%
• Tissue Factor Pathway Inhibitor 16%
• Intravascular Ultrasound 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronary Artery Atherosclerosis 100%
• Restenosis 100%
• Atherosclerosis 50%
• Ischemic Heart Disease 50%
• Acute Coronary Syndrome 50%
• Disease 33%
• Syndrome 16%
• Hyperplasia 16%
• Scar Formation 16%
• Tissue Factor Pathway Inhibitor 16%
• In-Stent Restenosis 16%
• Foreign Body 16%
• Coronary Risk 16%
• Granulomatous Inflammation 16%
• Vascular Remodeling 16%